Congestive ischemic colitis successfully treated with antiinflammatory therapy: A case report  

作　　者：Geon Woo Lee Su Bum Park 

机构地区：[1]Department of Internal Medicine,Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology,Pusan National University Yangsan Hospital,Yangsan 50612,South Korea

出　　处：《World Journal of Clinical Cases》2024年第1期142-147,共6页世界临床病例杂志

摘　　要：BACKGROUND Congestive ischemic colitis is a rare subtype of ischemic colitis with an unknown pathophysiology.Excluding conservative management,such as fasting,no established treatment exists;therefore,surgical intervention should be considered in some cases if symptoms worsen.Current literature suggests that anti-inflam-matory agents may effectively treat congestive ischemic colitis.CASE SUMMARY We present the case of a 68-year-old female patient who underwent laparoscopic left hemicolectomy for transverse colon cancer 3 years ago.Postoperatively,follow-up included an annual colonoscopy and abdominal computed tomography(CT)at a local clinic.However,progressive erythema and edema of the sigmoid colon were observed 1 year postoperatively.Upon admission to our hospital,she complained of abdominal pain and diarrhea.Abdominal CT showed thickening of the sigmoid colon walls,and colonoscopy revealed erythema,edema,and multiple ulcers with exudate in the sigmoid colon.CT angiography showed engorgement of the sigmoid vasa recta without any vascular abnormalities.The diagnosis was congestive ischemic colitis,and we treated the patient with anti-inflammatory agents.After 2 mo of glucocorticoid therapy(20 mg once daily)and 7 mo of 5-aminosalicylate therapy(1 g twice daily),the ulcers completely healed.She has not experienced any recurrence for 2 years.CONCLUSION Anti-inflammatory therapy,specifically glucocorticoids and 5-aminosalicylate,has demonstrated promising efficacy and introduces potential novel treatment options for congestive ischemic colitis.

关 键 词：Ischemic colitis GLUCOCORTICOIDS 5-aminosalicylate Colon cancer 

分 类 号：R574.62[医药卫生—消化系统]